期刊文献+

糖尿病肾病患者凝血与纤溶平衡变化的研究 被引量:33

Abnormal balance of coagulation and fibrinolysis in diabetic nephropathy
下载PDF
导出
摘要 目的 探讨糖尿病肾病患者的凝血、纤溶状态。方法  35例 2型糖尿病、糖尿病肾病 (DN)患者和慢性肾小球肾炎 (CGN)患者 2 9例 ,按是否合并肾病综合征 (NS)分为 :DN- NNS组 19例 ,DN- NS组 16例 ,CGN- NNS组 16例 ,CGN- NS组 13例。酶联免疫吸附法系统检测各项凝血和纤溶指标。结果 无论是否合并 NS,DN患者较 CGN组血中TM、PF1 + 2 、TAT、FPA及 PAI-水平明显增加。 Objective To investigate the states of coagulation and fibrinolysis in diabetes nephropathy.Methods Thirty five patients with type 2 diabetes and diabetic nephropathy (DN) and twenty nine patients with chronic glomerulonephritis (CGN) were divided into four groups according to with or without nephritic syndrome (NS). Those included 19 DN patients without NS as DN NNS group, 16 DN patients with NS as DN NS group, 16 CGN patients without NS as CGN NNS group and 13 CGN patients with NS as CGN NS group. The parameters of coagulation fibrinolysis were measured by ELISA.Results Regardless of whether with or without NS, the levels of thrombomodulin, prothrombin fragment 1+2, thrombin antithrombin Ⅲ complex, fibrinopeptid A and plasminogen activator inhibitor 1 were significantly higher in DN patients compared with CGN patients.Conclusion Compared with CGN patients, DN patients have more hypercoagulation state.
出处 《中国糖尿病杂志》 CAS CSCD 2002年第2期95-97,共3页 Chinese Journal of Diabetes
关键词 糖尿病肾病 慢性肾小球肾炎 血液凝固 凝血 纤溶异常 Diabetic nephropathy Chronic glomerulonephritis Coagulation fibrinolysis
  • 相关文献

参考文献6

  • 1[2]Ishii H, Majerus PW. Thrombomodulin is present in human plasma and urine. J. Clin. Invest. 1985, 76(6):2178.
  • 2[4]Davies PF, Tripathi SC. Mechanical stress mechanism and the cell.An endothelial paradigm. Circ Res, 1993,72(2):239.
  • 3[6]Lehmann R, Schleicher ED. Molecular mechanism of diabetic nephropathy. Clin Chim Acta, 2000,297(1-2):135.
  • 4[7]Ceriello A, Quatraro A, Giugliano D. New insights on nonenzymatic glycosylation may lead to therapeutic approaches for the prevention of diabetic complications. Diabet Med, 1992,9 (3): 297.
  • 5[8]Maiello M, Boeri D, Podesta F, et al. Increased expression of tissue plasminogen activator and its inhibitor and reduced fibrinolytic potential of human endothelial cells cultured in elevated glucose.Diabetes, 1992,41(8) :1009.
  • 6[9]Shimomura I, Funahashi T, Takahashi M, et al. Enhancedexpression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity. Nature Med, 1996,2(7):800.

同被引文献189

引证文献33

二级引证文献131

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部